Medigene

Medigene FCF per Share

Delisted·Jul 2, 2026

The Free Cash Flow per Share of Medigene (MDG1.DE) as of Oct 19, 2026 is -0.64 EUR. In the previous year, Free Cash Flow per Share was 0.45 EUR — a change of -243.89% (lower).

FCF per Share

-0.64EUR

YoY

-243.89%

Last updated:

Free Cash Flow per Share of Medigene is 2023 -0.64 EUR. Free Cash Flow per Share of Medigene was 2022 0.45 EUR. It decreases by -243.89% lower compared to the previous year.

The Medigene FCF per Share history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

FCF per Share
Date
FCF per Share
Jan 1, 2016
-0.22 EUR
Jan 1, 2017
-0.91 EUR
Jan 1, 2018
-0.45 EUR
Jan 1, 2019
-0.73 EUR
Jan 1, 2020
-0.98 EUR
Jan 1, 2021
-0.42 EUR
Jan 1, 2022
0.45 EUR
Jan 1, 2023
-0.64 EUR
The Medigene FCF per Share history
YEARFCF per ShareYoY
-0.64EUR-243.89%
0.45EUR-206.18%
-0.42EUR-56.95%
-0.98EUR+34.43%
-0.73EUR+60.01%
-0.45EUR-50.23%
-0.91EUR+308.92%
-0.22EUR-54.07%
-0.49EUR-38.39%
-0.79EUR—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Medigene Stock analysis

What does Medigene do? Medigene AG, based in Planegg, Germany, is a biotechnology company specializing in developing innovative cancer treatment platforms. The company focuses on personalized T cell-based immunotherapies, including TCR-modified T cells for adoptive therapy, dendritic cell vaccines for low tumor burdens, and T-cell-specific monoclonal antibodies. It operates offices in Martinsried, Germany, and in Washington DC and San Diego, USA, with 136 employees. Medigene is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Medigene stock

Free Cash Flow per Share of Medigene is -0.64 EUR in 2023.

Free Cash Flow per Share of Medigene changed from 0.45 EUR to -0.64 EUR, representing a -243.89% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Free Cash Flow per Share Medigene since 2006 – with annual values, charts, and detailed analysis.

FCF per share measures the free cash flow allocated to each outstanding share. It is a key metric for assessing shareholder value creation.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Cash Flow — Medigene

All Key Metrics — Medigene